Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2012
02/02/2012US20120027879 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
02/02/2012US20120027878 Natural lycopene concentrate and method for production thereof
02/02/2012US20120027875 Compositions for Treatment of Skin and Ear Infections
02/02/2012US20120027874 Compounds useful as inhibitors of atr kinase
02/02/2012US20120027873 Combination of a chemotherapeutic agent and an inhibitor of the tgf-beta system
02/02/2012US20120027871 Method of treatment based on polymorphisms of the kcnq1 gene
02/02/2012US20120027864 Coated drug delivery formulations
02/02/2012US20120027863 Pharmaceutical Compositions for Inhalation
02/02/2012US20120027862 Azelaic acid-comprising formulation with added pigment
02/02/2012US20120027861 Nano-carrier, complex of anticancer drug and nano-carrier, pharmaceutical composition thereof, method for manufacturing the complex, and method for treating cancer by using the pharmaceutical composition
02/02/2012US20120027859 Biodegradable Proline-Based Polymers
02/02/2012US20120027857 Controlled release pharmaceutical compositions comprising o-desmethyl-venlafaxine
02/02/2012US20120027856 Pharmaceutical product comprising yeast
02/02/2012US20120027855 Pharmaceutical compositions for gastrointestinal drug delivery
02/02/2012US20120027854 Pharmaceutical composition comprising ezetimibe and simvastatin
02/02/2012US20120027853 Process for preparation of anti-tubercular combination and pharmaceutical composition prepared therefrom
02/02/2012US20120027852 Pharmaceutical composition containing a "limus" family immunosuppressive macrolide
02/02/2012US20120027851 Method of reducing somnolence in patients treated with tizanidine
02/02/2012US20120027849 Stable pharmaceutical composition for atherosclerosis
02/02/2012US20120027846 Anti-viral azide containing compounds
02/02/2012US20120027844 Compounds, their syntheses, compositions, and methods to treat cancer
02/02/2012US20120027842 Topical formulations of flap inhibitors for administration to an eye
02/02/2012US20120027834 Methods of treatment with syk inhibitors
02/02/2012US20120027833 Drug-eluting films
02/02/2012US20120027823 Methods of treatment using a gastric retained gabapentin dosage
02/02/2012US20120027821 Amino acid-conjugated cyanoacrylate polymer particles
02/02/2012US20120027820 Stable Formulations for Lyophilizing Therapeutic Particles
02/02/2012US20120027819 Medical Devices Incorporating a Bioactive and Methods of Preparing Such Devices
02/02/2012US20120027818 Bisphosphonate product in a cycloolefinic polymer container
02/02/2012US20120027817 Absorbable Implants and Methods for Their Use in Hemostasis
02/02/2012US20120027816 Highly pure eletriptan or a pharmaceutically acceptable salt thereof substantially free of eletriptan n-oxide impurity
02/02/2012US20120027815 Use of plasma membrane calcium atpase (pmca) inhibitors to inhibit sperm mobility
02/02/2012US20120027814 Polymeric Fibers Having Tissue Reactive Members
02/02/2012US20120027812 Intraocular lenses treated with alkylphosphocholines for pharmacological aftercataract prophylaxis
02/02/2012US20120027811 Formulations of Viable Cells for Oral Delivery
02/02/2012US20120027809 Pharmaceutical compositions comprising water-soluble sulfonate-protected nanoparticles and uses thereof
02/02/2012US20120027803 Biodegradable lipids for the delivery of active agents
02/02/2012US20120027796 Novel lipids and compositions for the delivery of therapeutics
02/02/2012US20120027791 Antisense compound for inducing immunological tolerance
02/02/2012US20120027790 Immunological herpes simplex virus antigens and methods for use thereof
02/02/2012US20120027787 Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
02/02/2012US20120027785 Chimera comprising bacterial cytotoxin and methods of using the same
02/02/2012US20120027777 Ljungan virus with improved replication characteristics
02/02/2012US20120027766 Methods and means for treatment of osteoarthritis
02/02/2012US20120027762 Immunogenic compositions and diagnostic and therapeutic uses thereof
02/02/2012US20120027761 Treatment of Inflammatory Diseases by Inhibiting Cold-Inducible RNA-Binding Protein (CIRP)
02/02/2012US20120027753 MicroRNAs in Never-Smokers and Related Materials and Methods
02/02/2012US20120027752 Methods and compounds for treating paramyxoviridae virus infections
02/02/2012US20120027744 Modified heparinase iii and methods of sequencing therewith
02/02/2012US20120027738 Maternal supplement
02/02/2012US20120027735 Symbiotic maple product compositions and methods
02/02/2012US20120027733 Compositions to effect neuronal growth
02/02/2012US20120027723 Taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
02/02/2012US20120027721 HCV Inhibitor and Therapeutic Agent Combinations
02/02/2012US20120027719 Polyester Based Degradable Materials and Implantable Biomedical Articles Formed Therefrom
02/02/2012US20120027718 Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
02/02/2012US20120027714 Segmented Polymers and Their Conjugates
02/02/2012US20120027707 Lycogen extract, composition thereof and method for the treatment using the same
02/02/2012US20120027698 Cosmetic and/or pharmaceutical composition comprising at least one copolymer comprising at least one ionizable group, and cosmetic treatment process
02/02/2012US20120027693 Methods and compositions for preventing and relieving muscle cramps and for recovery from neuromuscular irritability and fatigue following exercise
02/02/2012US20120027692 Pyrrolopyrimidinedione and its therapeutic use
02/02/2012US20120027691 Cinnamic Acid-Based Oligomers and Uses Thereof
02/02/2012US20120027690 Ph-sensitive graft copolymer, manufacturing method for same, and polymer micelles using method
02/02/2012US20120027682 Pyrazine Derivatives for Optical Imaging and Therapy
02/02/2012US20120027680 Oxime conjugates and methods for their formation and use
02/02/2012US20120024743 Transdermal pharmaceutical preparations
02/02/2012US20120024308 Method of making up with light-sensitive makeup using a photochromic composition in the already-developed state
02/02/2012CA2843265A1 Peripherally restricted faah inhibitors
02/02/2012CA2810163A1 A method of managing broncho-constrictive condition
02/02/2012CA2809113A1 P2x4 receptor antagonist
02/02/2012CA2808797A1 Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptor agonists in combination with acetylcholinesterase inhibitors
02/02/2012CA2807199A1 Aryl hydrocarbon receptor (ahr) modifiers as novel cancer therapeutics
02/02/2012CA2807097A1 Matrix metalloproteinase inhibitors
02/02/2012CA2807006A1 Treatment of metabolic syndrome and insulin resistance with citrus flavanones
02/02/2012CA2806982A1 Compounds and methods for skin repair
02/02/2012CA2806942A1 Compounds for the treatment/prevention of ocular inflammatory diseases
02/02/2012CA2806823A1 Use of a mixture of probiotic bacteria in a mixture with short - chain fatty acids
02/02/2012CA2806821A1 Fused ring pyridine compound
02/02/2012CA2806820A1 N-methylformamide solvate of dasatinib
02/02/2012CA2806819A1 Regulation of glypican 4 activity to modulate the fate of stem cells and uses thereof
02/02/2012CA2806766A1 Therapeutic agent for neurological diseases
02/02/2012CA2806740A1 Use of rasagiline for the treatment of olfactory dysfunction
02/02/2012CA2806737A1 Dispersions of rasagiline citrate
02/02/2012CA2806655A1 Substituted imidazo[1,2-b]pyridazines
02/02/2012CA2806633A1 Cis-tetrahydro-spiro(cyclohexane-1,1'-pyrido[3,4-b]indole)-4-amine derivatives
02/02/2012CA2806610A1 Bicyclic azaheterocyclic carboxamides as inhibitors of the kinase p70s6k
02/02/2012CA2806606A1 Pharmaceutical compositions for the treatment of left ventricular diastolic dysfunction comprising an apolipoprotein peptide/phospholipid complex
02/02/2012CA2806565A1 Hydrated sodium salt form of celecoxib
02/02/2012CA2806450A1 Process for the esterification of hyaluronic acid with hydrophobic organic compounds
02/02/2012CA2806341A1 Ampk-activating heterocyclic compounds and methods for using the same
02/02/2012CA2806332A1 Quinoline derivatives and melk inhibitors containing the same
02/02/2012CA2806153A1 Compositions for treating heartworm infestation
02/02/2012CA2806133A1 Compositions for controlling heartworm infestation
02/02/2012CA2806094A1 Composition and method for photodynamic disinfection
02/02/2012CA2806008A1 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
02/02/2012CA2806006A1 Vinylogous chalcone derivatives and their medical use
02/02/2012CA2805766A1 Phenylalkyl n-hydroxyureas for treating leukotriene related pathologies
02/02/2012CA2805760A1 Inhibition of cyp3a drug metabolism
02/02/2012CA2805494A1 6-(1-methyl-1h-pyrazol-4-yl)-3-(2-methyl-2h-indazol-5-ylthio)-[1,2,4] triazolo [4,3-b] pyridazine as a c-met inhibitor
02/02/2012CA2805371A1 Therapeutic agent or prophylactic agent for neuropathic pain
1 ... 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 ... 7860